News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Karl Semaan received the Outstanding Research Award at KCRS24
Photo from Karl Semaan/X
Jul 15, 2024, 06:31

Karl Semaan received the Outstanding Research Award at KCRS24

Sylvan Baca, GU oncologist and computational epigenomics enthusiast at Dana-Farber Cancer Institute, shared on X:

“Congratulations to Karl Semaan on his Outstanding Research Award at KCRS24! Well deserved for his research on blood biomarkers of sarcomatoid RCC that I believe will make a difference for patients.”

Karl Semaan

Source: Sylvan Baca/X

blood biomarkers cancer Dana-Farber Cancer Institute Karl Semaan KCRS24 Kidney CAN OncoDaily Oncology Outstanding Research Award RCC sarcomatoid RCC Sylvan Baca
Special Coverage
Insight
Nov 3, 2024, 17:46
Rana McKay: Evaluating ACP1 expression in prostrate cancer
Insight
Nov 3, 2024, 17:23
Talha Badar: A predictive model for therapy failure in patients with CML receiving TKI therapy
Insight
Nov 3, 2024, 17:05
Vincent Rajkumar: Survival improvement in patients with HIV associated B cell lymphoma that adopted the Medicaid expansion of ACA
Blog
Nov 3, 2024, 16:51
Addressing cancer disparities among Black women - American Cancer Society
Blog
Nov 3, 2024, 16:48
Mohit Manrao: Discussing cancer innovation and biomarkers at the STAT Summit
Blog
Nov 3, 2024, 16:46
Lindsey Gasparini: New FDA-approved therapy targets Claudin18.2 in gastric cancers
Blog
Nov 3, 2024, 16:45
Nermean Mostafa: Launching a new oncology training platform in Egypt
Blog
Nov 3, 2024, 16:35
Jasmine Kamboj: Honored to be on the ballot for the Designated Community Oncology seat
Blog
Nov 3, 2024, 16:34
Crystal Denlinger: Our biannual guidelines harmonization update meeting
Blog
Nov 3, 2024, 16:30
Yale University's $150M investment into AI leadership is equipping medstudents with the tools to tackle tomorrow's healthcare challenges
Insight
Nov 3, 2024, 16:27
Alessandro Di Federico: EFS in patients with resectable NSCLC treated with neoadjuvant Chemo-IO
Blog
Nov 3, 2024, 16:25
Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance